(2001). Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology
(2002). Global cancer statistics
(2006). Greenberg NM: Targeting Aurora kinases for the treatment of prostate cancer. Cancer Res
(2002). HC: Downregulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation.
(2004). HC: High alphafetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
(2004). HC: Overexpression and amplification of Aurora-A in hepatocellular carcinoma. Clin Cancer Res
(2002). Hepatocellular carcinoma: an epidemiologic view.
(2007). Hsu HC: Overexpression of KIAA0101 predicts high stage, early tumor recurrence, and poor prognosis of hepatocellular carcinoma. Clin Cancer Res
(2003). Hsu HC: Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma. Cancer
(2007). KL: Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis. Gastroenterology
(2000). Lemeshow S: Applied logistic regression.
(1999). Lemeshow S: Applied survival analysis: regression modeling of time to event data.
(2008). Novel advancements in the management of hepatocellular carcinoma in
(1993). P: S26 ribosomal protein RNA: an invariant control for gene regulation experiments in eukaryotic cells and tissues. Nucleic Acids Res
(1991). Peng SY: Clonality and clonal evolution of hepatocellular carcinoma with multiple nodules. Hepatology
(1993). Peng SY: Expression of p53 gene in 184 unifocal hepatocellular carcinomas: association with tumor growth and invasiveness. Cancer Res
(2000). Peng SY: ß-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis.
(1994). PH: Mutations of p53 gene in hepatocellular carcinoma (HCC) correlate with tumor progression and patient prognosis: a study of 138 patients with unifocal HCC.
(2005). Portella G: Aurora B overexpression associates with the thyroid carcinoma undifferentiated phenotype and is required for thyroid carcinoma cell proliferation.
(2007). Roles of Aurora kinases in mitosis and tumorigenesis. Mol Cancer Res
(2007). S: AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis. Clin Cancer Res